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ABSTRACT

FRAGILE X MENTAL RETARDATION PROTEIN: SELF-REGULATION AND
miRNA PATHWAY INVOLVEMENT

By
Anna Blice-Baum
August 2013

Dissertation supervised by Dr. Mihaela-Rita Mihailescu
Fragile X syndrome, the most common form of inherited mental impairment in
humans, affects 1 of 4000 males and 1 of 8000 females. It is caused by the absence of
the fragile X mental retardation protein (FMRP), resulting from a CGG trinucleotide
repeat expansion in the 5’-untranslated region (UTR) of the fragile x mental retardation1 (FMR1) gene, and subsequent translational silencing of FMRP.

FMRP, a proposed

translational regulator of neuronal messenger RNA (mRNA) targets, has three RNA
binding domains: two K-homology domains (KH1 and KH2) and one arginine-glycineglycine (RGG) box domain. FMRP RGG box has been shown to bind with high affinity
to G-quadruplex forming mRNAs. G-quadruplexes are formed by stacked G-quartets
bonded by Hoogsteen base pairing and stabilized by monocations. FMRP undergoes
alternative splicing, including the alternative splice site at exon 15, giving rise to FMRP
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minor isoforms, truncated within close proximity of the RGG box domain. The binding
of FMRP to a proposed G quadruplex structure in the coding region of its own mRNA
named FBS has been proposed to affect mRNA splicing events for FMRP minor
isoforms. In this study we used biophysical methods to directly demonstrate the folding
of FMR1 FBS into two specific G-quadruplexes and analyze its binding by the FMRP
isoforms. Additionally, we analyzed the binding of an FMRP mutant in which Ser500
was replaced with Asp500 (ISOP), mimicking FMRP phosphorylation. We showed that
the minor splice isoforms bind more tightly to the FBS mRNA, suggesting a negative
feedback loop of FMRP binding to its mRNA to regulate alternate splicing.
FMRP associates directly with the Ago1 protein, a key component in the
microRNA (miRNA) pathway.

Interestingly, one of the FMRP mRNA targets, the

microtubule associated protein 1B (MAP1B) mRNA, has a G-quadruplex structure in its
5’-UTR shown to be bound by the FMRP RGG box, and a potential binding site for the
miRNA let-7b in its 3’-UTR. In this study we investigated the binding of the let-7b
miRNA to this sequence within MAP1B mRNA by using biophysical methods. Dr. Yue
Feng at Emory University confirmed the translation regulation of let7b miRNA on
MAP1B mRNA.
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CHAPTER 1: INTRODUCTION

1.1

Fragile X Syndrome: Background
In 1943, J. Purdon Martin and Julia Bell discovered a form of mental disability

that was associated with the X chromosome (1). In 1969 and 1970, Herbert Lubs and
Frederick Hecht located the irregular chromosome structure responsible for the mental
retardation on the X chromosome and named it the “fragile site” (2). Over two decades
later, the specific gene defect found on the fragile X mental retardation gene (FMR1) was
discovered in patients with fragile X syndrome (FXS) (3). FXS is the most common
form of inherited mental retardation in humans, affecting approximately one in 3000
males and one in 5000 females (4). Diagnosed individuals display impaired mental
function, hyperactivity, and a 30% chance of autism, as well as physical abnormalities,
such as elongated face and hands, large ears, and macroorchidism in males (5).

1.2

Gene mutation of Fragile X Syndrome
In the vast majority of cases, the phenotype of FXS described above is caused by

the absence of a single protein required for normal neuronal function, named the fragile
X mental retardation protein (FMRP) (6, 7). Transcriptional silencing of FMRP is caused
by the expansion of a region of cytosine-guanine-guanine (CGG) repeats in the 5untranslated region (5’-UTR) of the FMR1 gene by an unknown mechanism. When this
region expands to over 200 repeats, the cytosines become hypermethylated (7).

In

normal X chromosome gene regulation, methylation of cytosine causes inactivation of
transcription. Thus, the unnatural hypermethylation of the CGG repeat expansion region
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in FXS patients is thought to block normal transcription factors, causing the
transcriptional silence of the FMR1 gene. There have been extensive studies of FMRP
given that the loss of the protein has been implicated in FXS (8, 9), but its role in normal
brain function has not yet been fully explained, and the exact mechanism of how its loss
leads to mental retardation is not known.

1.3

Fragile X Mental Retardation Protein
FMRP is an RNA binding protein expressed in most tissues, but found

predominantly in the dendritic spines of neurons and the testes (6). The protein contains
two different types of RNA binding domains: two K-homology domains and one
arginine-glycine-glycine (RGG) box domain, as well as a nuclear localization signal
(NLS) and a nuclear export signal (NES), which allow the protein to shuttle between the

Figure 1.1 A schematic representation of the full-length FMRP, which shows the nuclear
localization signal (NLS), the two K-homology domains (KH1 and KH2), the nuclear
export signal (NES), the site of phosphorylation (P) and the RGG box (RGG). Isoforms
1 – 3, resulting from the alternative splicing at exon 15 of FMR1 mRNA are also
illustrated. The phosphorylation of serine 500 (red) has been shown to be biologically
relevant. Adapted from (10).
2

Figure 1.2 A proposed mechanism of FMRP function in neuronal cells. FMRP is
transported into the nucleus of a neuronal cell by way of its NLS (1), wherein it
associates with cellular mRNAs and proteins forming larger ribonucleoprotein (RNP)
complexes (2). that are transported out of the nucleus into the cytoplasm via the NES (3).
Once in the cytoplasm, FMRP can either transport its bound mRNA to ribosomes (4) for
protein production (5) in response to mGluR stimulation and then transport the protein
products to neurites (6, 7), or it can transport mRNAs to dendrites (8) and then allow for
protein production of its own message or its mRNA targets (9) in response to mGluR
stimulation (10). (6) Reprinted with permission from the publisher.
3

nucleus and cytoplasm of a cell (6, 11, 12). A schematic of the full-length FMRP as well
as the splice variants of ISO1, ISO2, and ISO3 produced by alternative splicing at exon
15 are shown in figure 1.1 (10). In addition, FMRP has been shown to undergo the
posttranslational modifications of phosphorylation and arginine methylation (13, 14).
Since it binds to mRNAs as part of large ribonucleoprotein (mRNP) complexes, FMRP is
postulated to be involved in regulating the translation of specific neuronal messenger
RNA (mRNA) targets in response to synaptic output, although the mechanism of this is
not well understood (15). The proposed mechanism of FMRP function as an RNA
binding protein begins with FMRP being transported into the nucleus of a neuronal cell
by way of its NLS, wherein it associates with cellular mRNAs and proteins in order to
form larger ribonucleoprotein (RNP) complexes (figure 1.2).

These RNPs are then

transported out of the nucleus into the cytoplasm where FMRP can either transport its
bound mRNA to ribosomes for protein production in response to mGluR stimulation and
then transport the protein products to neurites, or it can transport mRNAs to neurites and
then allow for protein production in response to mGluR stimulation (6). FMRP is known
to bind to about 4% of all neuronal messages, although the detailed mechanisms by
which it recognizes its targets are not fully understood (16).
Several FMRP isoforms can be produced through alternative splicing events that
involve the inclusion/skipping of exons 12 and 14, as well as three acceptor sites at exon
15 and two at exon 17 (17, 18). Figure 1.3 is a schematic of the splicing patterns that are
possible due to alternative splicing in the FMR1 gene (18). In mouse models of the
FMR1 gene, it was found that although mRNA transcripts of isoforms 1 – 12 vary in
concentration by as much as two orders of magnitude, all of the transcripts were
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associated with polyribosomes, which is consistent with the translation of the FMR1
mRNA transcripts. The distribution of the isoforms of FMR1 is consistent with the
different developmental stages of the cells investigated, emphasizing the implications of
losing all isoforms in FXS. The three isoforms investigated in this study are FMRP
isoforms 1, 2, and 3 (ISO1 – ISO3), which are created using the three acceptor sites at
exon 15 and inclusive of exons 12 and 14 (figure 1.3). All three isoforms contain the KH
domains as well as the RGG box domain, which has been shown to bind to G-quadruplex
forming mRNA targets (figure 1.1).

Figure 1.3 Schematic representation of the alternate splicing of FMR1 mRNA into
isoforms 1 through 12: adapted from (18).

5

1.4

G-quadruplex structures
G-quadruplexes were first discovered in 1962 when Gellert and colleagues

assembled X-ray diffraction data on a tetrameric helical structure formed by guanylic
acid (19), after which it was revealed that similarly structured poly-guanosine oligomers
adopted the same structure in DNA and RNA (20, 21). The best characterized DNA
sequences that have been shown to form G-quadruplex structures are the intramolecular
telomeric sequences, which are found at the ends of eukaryotic chromosomes (22-24) and
whose purpose is to block telomere elongation by cancer-associated telomerase (25, 26).
The role of G-quadruplex formation in genes seems to be mainly in gene regulation as
they are predominantly found in promoter regions of genes at the transcriptional level
(26). G-quadruplexes may be more prevalent in RNA than in DNA because RNA is
single-stranded more often than DNA, allowing for the formation of G-quadruplex
structures due to the availability of bases that are not involved in Watson-Crick base
pairing (26, 27). Almost 3000 mRNAs have regions in their 5’-UTR that potentially
form G-quadruplex structures, leading to the belief that the presence of this secondary
structure is important in gene expression at the translational level (26, 28). G-rich RNA
and DNA sequences have also been implicated in the alternative splicing of several genes
(29). G-quadruplex structures are characterized by two or more stacks of planar Gquartets that are held together by Hoogsteen base pairing and stabilized by monocations,
the potassium ion (K+) providing the most thermodynamic stability (figure 1.4 A) (30,
31). Depending on the direction of each strand of RNA involved in the interaction, Gquadruplex structures can be described as parallel or antiparallel (figure 1.4 B). An
intramolecular G-quadruplex may form from one strand of DNA or RNA folding in on
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itself, while an intermolecular G-quadruplex may form when more than one strand of
DNA or RNA interacts with each other. Intramolecular G-quadruplex RNA sequences
are described as containing four distinct runs of two or more guanine bases that can form
stable G-quadruplex structures by themselves from a single strand of RNA (32).

Figure 1.4 A structure of a G-quartet with Hoogsteen hydrogen bonding between
guanines stabilized by K+ ions. These quartets stack on top of one another to form a Gquadruplex RNA structure further stabilized by K+ ions (A). Parallel versus antiparallel
G-quadruplex structures (B).
Several biophysical methods have been used to characterize G-quadruplex
formation in DNA and RNA.
resonance

(NMR)

Some of these methods include nuclear magnetic

spectroscopy,

circular

electrophoresis, and x-ray crystallography.

dichroism

(CD)

spectroscopy,

gel

The imino protons involved in the

characteristic Hoogsteen base-pairing in G-quadruplex formation resonate in the range 10
– 12 ppm in the 1H-NMR spectrum in contrast to the range 12 – 15 ppm for imino
protons involved in Watson-Crick base pairing (33).

CD spectroscopy is used to

characterize G-quadruplexes as parallel or antiparallel (Figure 1.4 B).

Parallel G-

quadruplexes possess a positive band at 265 nm and a negative band at 240 nm (34, 35)
7

while antiparallel G-quadruplexes typically possess two positive bands, one at 290 nm
and one at 245 nm, and one negative band at 265 nm (36) (Figure 1.5). Interestingly, Aform RNA

Figure 1.5 Example of CD spectra from parallel G-quadruplex formation with a positive
band at 265 nm and a negative band at 240 nm and antiparallel G-quadruplex formation
with positive bands at 290 nm and 245 nm and a negative band at 265 nm.

has a positive band at 260 nm, and B-DNA has a negative band at 245 nm and a positive
band at 275 nm (37), both of which are in close proximity of the bands seen for Parallel
G-quadruplex RNA formation. However, if CD spectroscopy experiments are performed
in conjunction with

1

H-NMR spectroscopy showing characteristic peaks for G-

quadruplex imino protons rather than Watson-Crick base-paired imino protons, then the
CD spectra can be interpreted as characterizing parallel G-quadruplexes rather than any
other secondary structure of RNA.
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1.5

FMRP recognition of its mRNA targets
The RGG box domain of FMRP is characterized by two arginine-glycine-glycine

repeats within close proximity of each other within the FMRP amino acid sequence (38).
44 human RNA binding proteins have been found to contain an RGG box (39), but there
is no consensus sequence of the RNA binding domain. Several studies have shown that
the RGG box domain of FMRP binds with high affinity to mRNA targets that form Gquadruplex structures (15, 40, 41).
It is thought that the RGG box domain is dynamic in nature, becoming structured
upon binding with G-quadruplex forming mRNA. Recently, a solution structure of the
RGG box domain peptide binding with a 36 nucleotide (nt) sequence sc1 RNA, a Gquadruplex model system, was solved by NMR spectroscopy (42).

The NMR

spectroscopy solution structure confirmed that the RGG box indeed becomes structured
upon binding to the G-quadruplex formed by the RNA sequence and revealed that the
RGG box binds to a junction between the G-quadruplex and a stem formed by the RNA
(10, 42). However, since this is the only RGG box-RNA structure available, it is not
clear if this mode of binding is unique to the synthetic sc1 RNA or a general mode of
RNA recognition by the RGG box. Several specific neuronal gene targets of FMRP have
been shown directly by biophysical methods to adopt G-quadruplex structures in their
mRNA sequences and to be bound with high affinity and specificity by the isolated
FMRP RGG box or the full-length FMRP isoforms (10, 43-45). These include the
mRNAs that encode for the microtubule associated protein 1B (MAP1B), post synaptic
density protein 95 (PSD95), and semaphorin 3F (S3F) (43, 45-49). MAP1B is a protein
that is involved in controlling microtubule dynamics and synapse formation (43, 50-52).

9

PSD95 is a protein component of the postsynapse that controls synapse strength and
stabilizes dendritic spines (47, 53, 54). S3F is involved in the maturation of neurons as
well as the induction of growth cone collapse (55, 56). All of the protein products of
these mRNA targets of FMRP are essential for the formation and maintenance of
neuronal cells, and the misregulation of these proteins due to the lack of FMRP
translation regulation in FXS patients may have implications in the development of
mental disability. Interestingly, it has been shown that the FMRP RGG box binds with
high affinity and specificity to a semaphorin 3F mRNA sequence that forms a Gquadruplex but does not include a stem structure (45). This finding suggests that the
FMRP RGG box might have different modes of recognition of its mRNA G-quadruplex
structures, considering that in the case of sc1 RNA the binding occurred at the junction
between a G-quadruplex and stem structure.
In addition to the RGG box RNA binding domain, FMRP contains two KH
domains (figure 1.1). KH domains were first discovered in the heterogeneous nuclear
ribonucleoprotein K in 1994 and have since been identified in many RNA binding
proteins to perform a multitude of cellular functions (57). The KH domain recognizes
RNA and single-stranded DNA sequences to perform its function, and two or more KH
domains are commonly found within the same protein. The KH domains of FMRP have
been shown to bind to RNAs that form kissing-complexes (58), however, no consensus
sequence was determined, and no FMRP mRNA targets that harbor kissing complexes
have been identified.

A kissing complex in RNA is formed by Watson-Crick base

pairing between the loops of two RNA hairpin structures. An FXS patient was found to
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harbor a missense mutation (I304N) within the second KH domain of FMRP, suggesting
that the KH domain is relevant for the protein function (58, 59).
Additionally, a patient recently diagnosed with FXS was found to have normal
levels of FMRP (unpublished data, Dr. Bassem Hassan, Katholieke Universiteit Leuven).
However, the analysis of the FMR1 gene revealed a frameshift mutation that essentially
abolishes the RGG box domain, truncates the C-terminus of the protein by creating a
premature stop codon, and changes the identity of the remaining residues after the
mutation position. The elimination of the RGG box domain in this patient who expresses
normal levels of FMRP illustrates the importance of this RNA binding domain in the
normal function of FMRP.

1.6

FMRP and the miRNA pathway
Recent lines of evidence connect FMRP directly with the microRNA pathway (7,

60-65). The miRNA pathway is shown in figure 1.6 (66, 67).

miRNAs are short,

noncoding RNA sequences encoded by the genome of a cell, with over 1,400 miRNAs
being identified in humans (68). miRNAs are 20 to 25 nucleotide single stranded RNAs
that have as a precursor longer strand RNAs processed and cleaved by the RNases
Drosha and Dicer (66). Primary miRNAs (pri-miRNAs) are initially transcribed by RNA
polymerase II and cleaved in the nucleus by the Drosha-DGCR8 complex to form premiRNAs, which are approximately 70 nucleotides in length. After the pre-miRNA is
exported from the nucleus by the Exp5-Ran complex, Dicer further cleaves the premiRNA in the cytoplasm to produce a miRNA duplex and finally the single miRNA
strand, which is incorporated into the RNA-induced silencing complex (RISC), a multi-

11

protein complex that involves the Argonaut class of proteins (7, 66, 69, 70). miRNAs
exert their translation regulation function by identifying and binding to target mRNA
sequences (66, 67, 71). The evidence of FMRP association with the RISC suggests that
the miRNA pathway may be involved in the exertion of the translation regulator function

Figure 1.6 Schematic representation of the miRNA pathway. In the nucleus, the miRNA
gene is transcribed into pri-miRNA, which is cleaved by the Dicer-Drosha complex into
pre-miRNA. Pre-miRNA is transported into the cytoplasm by Exp5-Ran complex, is
further cleaved by Dicer and bound by an Argonaut protein (Ago) in the RNA induced
silencing complex (RISC) to be used in either gene silencing (partial complementarity) or
mRNA cleavage (perfect or near perfect complementarity). Adapted and reprinted with
permission from the publisher from (67).
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of FMRP (7).

Given this connection, it is reasonable to inquire if the translation

regulation function of FMRP is mediated by the miRNA pathway. Interestingly, one of
the FMRP mRNA targets, the microtubule associated protein 1B (MAP1B) mRNA has in
its 5’-untranslated region (5’-UTR) a G-quadruplex structure that has been shown to be
bound with high affinity by the FMRP RGG box and in its 3’-UTR has a potential
binding site for the miRNA let-7b. In collaboration with Dr. Yue Feng from Emory
University, we investigated the in vitro binding of let-7b miRNA to the sequence within
the 3’-UTR of MAP1B mRNA (MAP1B seq1 RNA) by biophysical methods (Chapter 5).
The in vivo interactions between let-7b and the MAP1B 3’-UTR were also analyzed by
complementary experiments in normal and FMRP knockout (KO) mice, performed in our
collaborator’s, Dr. Yue Feng, laboratory at Emory University.

1.7

The FMRP binding sequence of FMR1 mRNA
FMRP has also been shown to interact with its own mRNA by binding to a 100

nucleotide G-rich region named the FMRP binding sequence (FBS), which was proposed
to fold into two distinct G-quadruplex structures (41, 72, 73). This finding prompted the
hypothesis that FMRP might use an autoregulatory loop to regulate its own translation
(41). However, in a subsequent study, it was shown that the FMRP interactions with FBS
do not affect the FMR1 mRNA stability and translation. The purine rich FBS region has
been found instead to be a potent exonic splicing enhancer whose function is dependent
on the presence of the G-rich region (72, 73). FBS is located in the proximity of the three
different acceptor sites at exon 15, and FMRP binding to FBS has been found to control
the splicing events at exon 15. Thus, an overexpression of FMRP ISO1 decreased the
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usage of the exon 15 first acceptor site, concomitant with an increased usage of the exon
15 second and third acceptor sites (72). This direct involvement of FMRP in regulating
the production of its minor isoforms created by the usage of exon 15 acceptor sites 2 and
3, which include ISO2 and ISO3, could add a new layer of regulation to the FMRP
translation regulator function, as these minor isoforms lack the major phosphorylation
site at position 500 (figure 1.1, red). The FMRP phosphorylation/dephosphorylation
events have been shown to play a major role in the association of FMRP with the miRNA
pathway, which might assist the protein in exerting its translation regulator function at
least for a subset of its mRNA targets that contain miRNA binding sites. Phosphorylated
FMRP has been found associated with the RNA induced silencing complex (RISC), the
microRNA miR-125a, and the postsynaptic density 95 (PSD95) mRNA, whereas its
dephosphorylation triggered by synaptic input leads to the dissociation of the RISC
complex from PSD95 mRNA, allowing for the translation of the PSD95 protein (47).
The fact that FMRP isoforms ISO2 and ISO3 lack the major site of phosphorylation
raises the possibility that these minor isoforms might control the timing and duration of
the “on” state for the translation of specific mRNA targets. Thus, their production has to
be tightly regulated, and this may be achieved by a feedback mechanism involving the
FBS exonic splicing enhancer.
It is of great interest to directly characterize the presence of a G-quadruplex
structure within the FBS sequence of FMR1 mRNA by biophysical methods to show that
FMRP indeed binds to its own mRNA in a G-quadruplex dependent manner, and this was
accomplished in the first part of this study (chapter 3). Furthermore, it is also relevant to
quantify the binding of major and minor isoforms of FMRP to this sequence by
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biophysical methods as it has been shown in vivo that the major isoform binding to this
sequence influences the production of the minor splice variants of the protein. This was
accomplished in the second part of this study, the results being summarized in chapter 4.

1.8

Specific Aims of the research
Specific Aim I: Direct characterization by biophysical methods of G-quadruplex
forming mRNA sequence(s) located in the RGG box coding region of FMR1
mRNA.

Specific Aim II: Characterization of the binding between several FMRP isoforms
and the G-quadruplex formed by FMR1 mRNA by biophysical methods.

Specific Aim III: Characterization of the binding of let7b miRNA to the 3’-UTR
of a known FMRP mRNA target, MAP1B mRNA.

1.9

Relevance of the research
The research performed in this project will increase our understanding of the role

played by FMRP in controlling the alternate splicing of its own mRNA. It is important to
directly prove that the G-rich FBS sequence of FMR1 mRNA forms a G-quadruplex to
which FMRP binds with high affinity. The fact that FMRP binds to its own mRNA in
order to regulate the alternate splicing into major and minor isoforms may have
implications in other regulatory processes modulated by FMRP as the minor splice
15

isoforms lack the site of phosphorylation in exon 15. Although the phosphorylation of
FMRP ISO1 has not been shown to affect its binding to the FBS sequence of FMR1
mRNA in this study, it has been shown and proposed to have importance in other aspects
of protein function. We have shown that the minor FMRP isoforms, ISO2 and ISO3,
bind more tightly to the FBS sequence of FMR1 mRNA, indicating that neuronal cells
utilize the negative feedback loop of FMRP binding to its own mRNA to regulate the
alternate splicing into minor isoforms.
Furthermore, the role of FMRP as a translational regulator is not fully understood,
and the results of the second part of this study could help elucidate how FMRP functions
in the presence of target mRNAs that contain both G-quadruplex structures and
complementary binding sequences for miRNAs. This research could be relevant beyond
the scope of fragile X syndrome to investigate how other proteins exhibit their
translational regulatory functions in the presence of miRNA.
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CHAPTER 2: MATERIALS AND METHODS

2.1 Synthesis of RNA in vitro
Unlabeled FBS_67 RNA, FBSsh RNA, FBS_Q1 RNA and FBS_Q2 RNA (table
2.1) oligonucleotides were synthesized in vitro off synthetic DNA templates (Trilink
Biotechnologies,

Inc.)

using

T7

RNA

polymerase

produced

in-house

(74).

Oligonucleotides were purified by 15% or 20% 8 M urea denaturing polyacrylamide gel

Table 2.1 Unlabeled RNA sequences

electrophoresis (PAGE), eluted from the gel pieces using electrophoretic elution, and
extensively dialyzed against 10 mM cacodylic acid, pH 6.5 (74).

A fluorescent

oligonucleotide was designed for FBSsh in which the highly fluorescent adenine analog
2-aminopurine (2AP) replaced the adenine at position 14 of FBSsh RNA to construct
FBSsh_14AP (Dharmacon, Inc.). Two unlabeled RNA sequences, MAP1B seq1 RNA
and let-7b miRNA, were synthesized by Dharmacon, Inc. as well since the sequences do
not begin with two guanines, a requirement for in vitro T7 RNA polymerase
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transcription.

Samples of FBS_67, Q1, and Q2 RNA sequences were annealed by

heating at 95 °C in the presence or absence of KCl and slow cooling to 25 °C for 30
minutes. All samples of FBSsh and FBSsh_14AP RNA were prepared by incubation in
the presence or absence of KCl at 25 °C for 20 minutes.

2.2

RGG box peptide synthesis
The FMRP RGG box peptide with the sequence N-RRGDGRRRGGGG

RGQGGRGRGGGFKGNDDHSR-C was chemically synthesized by the Peptide
Synthesis Unit at the University of Pittsburgh Center for Biotechnology and
Bioengineering.

2.3

Expression of recombinant FMRP isoforms
The recombinant pET21a-FMRP plasmid encoding FMRP isoform 1 (ISO1)

fused with a C-terminal 6X histidine tag was a kind gift from Dr. Bernhard Laggerbauer
(Institut für Molekularbiologie und Tumorforschung, Philipps-Universität Marburg,
Marburg, Germany). The truncations of the FMR1 gene encoding for FMRP ISO1 to
create the genes encoding for ISO2 and ISO3 were performed by GenScript USA, Inc.
and confirmed by sequencing at the University of Pittsburgh Genomics and Proteomics
Core. In order to recombinantly express, purify, and dialyze ISO2 and ISO3, we used the
previously developed protocol in our laboratory for the expression of FMRP ISO1 (75).
In brief, plasmids were transformed into Rosetta2(DE3)pLysS E. coli cells. All media
used in the cell growth consisted of Luria-Bertani (LB, Fisher Scientific) media
containing

200

µg/mL

ampicillin

(AMP,
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MP

Biomedical)

and
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µg/mL

chloramphenicol (CHL, MP Biomedical). Cells were incubated at 37 °C until the target
absorbance at 600 nm of 0.8 – 1.0 was reached, and protein expression was induced by
adding 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and incubating cells at 250
rpm and 25 °C for 12 hours. Cells were harvested, lysed, and purified using Ni-NTA
Superflow resin (Qiagen) as described (75). Purified proteins were concentrated using
dialysis tubing filled with polyethylene glycol (PEG) 20,000 and dialyzed into a buffer
devoid of K+, Na+, or imidazole. Final protein buffer consisted of 5% glycerol, 1 mM
EDTA, and 300 mM LiCl. The concentration of FMRP isoforms was determined at A280
by using the molar extinction coefficients of 46370 M -1cm-1 for ISO1 and ISO2 and
40680 M-1cm-1 for ISO3 (76, 77). The presence of the isoforms was analyzed using a
10% tris-glycine sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDSPAGE) and visualized by Coomassie blue staining.

2.4

Mass Spectrometry Analysis of FMRP ISO2 and ISO3
The identity of FMRP ISO2 and ISO3 was confirmed using peptide mass

fingerprinting (Genomics and Proteomics Core Laboratories, University of Pittsburgh).
FMRP ISO2 and ISO3 from a 10% SDS-PAGE gel was excised and trypsin digested
followed by analysis via matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF-MS).

Five MALDI-TOF-MS characterized amino acid

sequences matched those found in FMRP isoforms, and the one sequence corresponding
to exon 15 was truncated according to the splice variations of ISO2 and ISO3.
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2.5

Design of the phosphomimetic FMRP isoform 1, ISOP
FMRP ISO1 has been shown to be phosphorylated at 3 serine sites in exon 15,

serine 500 being shown to be biologically relevant (47, 78).

Sara Katrancha, an

undergraduate in the Mihailescu lab, designed a phosphomimetic version of FMRP ISO1
in which serine 500 was replaced by aspartic acid in order to mimic phosphorylation on
serine 500 (79). This phosphomimetic FMRP ISO1 (ISOP) mutation was performed by
GenScript USA, Inc. In order to recombinantly express, purify, and dialyze ISOP, the
previously developed protocol (75) for the expression of FMRP ISO1 was used as
described in section 2.4. The concentration of FMRP ISOP was determined at A280 by
using the molar extinction coefficients of 46370 M -1cm-1 (76). The presence of FMRP
ISOP was analyzed using a 10% tris-glycine sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and visualized by Coomassie blue staining.

2.6

UV spectroscopy
The melting curves of the RNA oligonucleotides were collected on a Varian Cary

3E spectrophotometer outfitted with a Peltier temperature control cell holder.
Experiments were carried out in a 10 mm path length 200 µL quartz cuvette (Starna
Cells) using samples prepared as follows in 10 mM cacodylic acid, pH 6.5 up to a final
volume of 200 µL. FBS_67 RNA, FBS_Q1 RNA and FBS_Q2 RNA were all prepared
by boiling the samples for 10 minutes and allowing them to cool to 25 °C for 30 minutes.
FBSsh RNA was prepared and incubated at 25 °C. Samples were heated from 25 °C to
95 °C at a rate of 0.2 °C per minute with points recorded every 1 °C. Samples and
reference cells were covered with 200 µL of mineral oil to prevent evaporation of
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aqueous solutions at high temperatures. Spectral absorbencies were monitored at either
295 nm or 305 nm, wavelengths that have been identified as being sensitive to Gquadruplex dissociation, depending on the absorbance of the RNA at different
concentrations (80).

All UV thermal denaturation experiments were performed in

duplicate. In order to determine the inter- or intramolecular conformation of the Gquadruplex, melting temperatures of various concentrations of RNA between 3 and 50
µM were recorded. Duplex denaturation between MAP1B seq1 RNA and let-7b miRNA
was monitored at 275 nm (81).

2.7

Circular Dichroism Spectroscopy
CD experiments were performed on a J-810 spectrapolarimeter at 25 °C using a

200 µL quartz cuvette with a 1 mm path length (Starna Cells). Parallel G-quadruplex
formation of the RNA oligonucleotides at 10 µM in 10 mM cacodylic acid, pH 6.5, was
observed as KCl was titrated in increasing concentrations from a 2 M stock, by
monitoring the change in molar ellipticity at 240 nm and 265 nm. Changes in molar
ellipticity at 240 nm and 265 nm were monitored for FBSsh RNA as RGG box peptide
was titrated into the sample from a 500 µM stock. Each spectrum was scanned 7 times
from 200 to 350 nm with a one second response time and a 2 nm bandwidth.

2.8

1D 1H-NMR spectroscopy
The one-dimensional (1D) 1H-NMR spectra of the RNA oligonucleotides were

acquired at 25 °C on a 500 MHz Bruker AVANCE spectrometer. Water suppression was
carried out by using the Watergate pulse sequence (82). Maximum concentrations of
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RNA oligonucleotides (200 µM to 1 mM) were prepared in 10 mM cacodylic acid, pH
6.5, in a 90:10 ratio of H2O:D2O. G-quadruplex formation was observed by titrating
increasing concentrations of KCl from a 2 M stock to each sample and allowing samples
to equilibrate for 10 minutes at 25 °C. Samples that were boiled were removed from the
NMR tube prior to boiling and replaced after they were cooled to 25 °C. The D2O
exchange experiment was carried out by lyophilizing the FBS_Q2 RNA sample and resuspending it in 250 µL of pure D2O, with spectra measured in the interval 10 minutes to
5 days at 25 °C.
The 1D 1H-NMR spectra of MAP1B seq1 RNA and let-7b miRNA duplex
formation was observed on a Bruker 900 MHz US2 spectrometer equipped with a
cryoprobe for increased sensitivity at the University of Pittsburgh NMR Core Facility.

2.9

2D 1H-1H NOESY
Two-dimensional (2D) homonuclear NOESY experiments with mixing times of

50 ms were recorded at 25 °C in 90%:10% H2O:D2O (82, 83). Data sets were processed
using XWIN-NMR (Bruker).

2.10

Native polyacrylamide gel electrophoresis (native PAGE)
Non-denaturing PAGE experiments on all RNA oligonucleotides were performed

using acrylamide from J.T. Baker and vertical gel apparatus from BioRad. Gels (15 %
for FBSsh and FBS_67 RNA and 20% for FBS_Q1 and FBS_Q2 RNA) were visualized
by UV shadowing at 254 nm (84) or staining in ethidium bromide or SYBR gold and
visualized on an AlphaImager (AlphaInnotech).
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FBS_67 RNA, FBS_Q1 RNA, and

FBS_Q2 RNA were prepared by heating to 95 °C for 5 minutes and allowing samples to
cool to 25 °C for 30 minutes. Samples of FBSsh RNA were prepared by incubation at 25
°C for 20 minutes. Gels were run at 4 °C from 40 to 75 V for 4 to 6 hours. FMRP RGG
box binding experiments were performed by preparing the RNA sequences as described
above and then incubating samples with RGG box peptide in different ratios at 25 °C for
an additional 30 minutes. Samples for native PAGE experiments on MAP1B seq1 RNA
and let-7b miRNA duplex formation were mixed and allowed to incubate at 25 °C for 20
minutes, loaded onto a 20% gel, and run at 75 V for 6 hours at 25 °C.

2.11

Fluorescence spectroscopy
Steady-state fluorescence spectroscopy experiments of FBSsh_14AP were

performed on a Horiba Jobin Yvon Fluoromax-3 and accompanying software fitted with
a 150 W ozone-free xenon arc lamp. Experiments were performed in a 150 µL sample
volume, 3 mm path-length quartz cuvette (Starna Cells). Excitation wavelength was set
to 310 nm, the emission spectrum was recorded in the range of 330 – 450 nm, and the
bandpass for excitation and emission monochromators were both set to 3 nm.

For

binding experiments, the temperature was set to 25 °C, and increasing concentrations of
FMRP isoforms (ISO1, ISO2, ISO3, and ISOP) were titrated in 15 nM increments to a
fixed RNA concentration of 150 nM. A ratio of 5:1 BSA:RNA was added to the RNA
sample before titration began. Emission values were corrected for free protein emission
of both BSA and FMRP isoforms, and the data was normalized to free RNA fluorescence
intensity monitored at 371 nm. Experiments were performed in triplicate, and the Kd of
each individual experiment was calculated by fitting the data to equation 2.1 and
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averaged with the other two with the error representing the standard deviation of the
average Kd.

Data shown is representative of individual experimental data with the

average Kd shown. IF and IB represent steady-state fluorescence intensities of free and
bound RNA, respectively, [RNA]t is the total fixed RNA concentration, and [P] t is the
total FMRP isoform concentration. The protein-RNA complex dissociation constant, Kd,
was determined for each experiment by fitting the binding curve with equation 2.1.
Reported errors are standard uncertainties of the averaged data from the best-fit
theoretical curves.

2.1
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CHAPTER 3: CHARACTERIZATION OF FBS RNA G-QUADRUPLEX
STRUCTURE(S)

3.1

Characterization of FBS_67 RNA
FMRP has been shown to interact with its own mRNA by binding to a 100

nucleotide G-rich region named the FMRP binding sequence (FBS), which was proposed
to fold into two distinct G-quadruplex structures (41, 72, 73) based on potassiumdependent stops of reverse-transcriptase that disappeared when mutations were
introduced to FBS RNA. The purine rich FBS region has been found instead to be a
potent exonic splicing enhancer whose function is dependent on the presence of the Grich secondary structures (72, 73). The FBS region of FMR1 mRNA is located near the
three acceptor sites of exon 15, and FMRP binding to this region has been shown to
control splicing events at exon 15. This direct involvement of FMRP in regulating the
production of its minor isoforms created by the usage of exon 15 acceptor sites 2 and 3,
which include ISO2 and ISO3, could add a new layer of regulation to the FMRP
translation regulator function, as these isoforms lack the major phosphorylation site at
amino acid position 500. It is of great interest to directly characterize the presence of (a)
G-quadruplex structure(s) within the FBS sequence of FMR1 mRNA by biophysical
methods to determine if FMRP indeed binds to its own mRNA in a G-quadruplex
dependent manner. Moreover, it is important to quantify the binding of major and minor
isoforms of FMRP to this sequence by biophysical methods, as it has been shown in vivo
that the major isoform binding to this sequence influences the production of the minor
splice variants of the protein (72).
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In this study, biophysical methods were employed to directly confirm the
existence and characterize the fold of the G-quadruplex structures in FMR1 mRNA.
Initially, we truncated FBS RNA to a 67 nt fragment (position 1590 – 1657 within the
FMR1 gene), named FBS_67 RNA, which retained the G-rich region proposed to fold
into two G-quadruplex structures. We chose this 67 nt sequence because it retained the
two proposed G-quadruplexes plus flanking nucleotides from the original 100 nt RNA
and because a shorter 67 nt RNA sequence had a higher chance of being successfully
transcribed in vitro compared to the original 100 nt sequence. FBS_67 RNA was

Figure 3.1 The 1H-NMR spectra of FBS_67 RNA confirms the formation of a Gquadruplex in the presence of increasing concentrations of KCl as seen by the increasing
of the intensity of the resonances between 10 and 12 ppm. Canonical base pairing, as
seen by resonances between 11.5 and 15 ppm, are also consistently present even as the Gquadruplex resonance intensities increase.
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produced by in vitro transcription reactions off a synthetic DNA template, and 1D 1HNMR spectroscopy was employed to analyze G-quadruplex formation in this sequence in
the absence and presence of KCl. A group of imino proton resonances centered around
11 ppm, which correspond to guanine imino protons involved in G-quartet formation,
were observed even in the absence of K+ ions (Figure 3.1, bottom spectrum). Imino
proton resonances were also observed in the region 12 – 15 ppm, corresponding to
guanine and uracil imino protons involved in Watson-Crick base pair formation (85),
indicating also the presence of a duplex and potentially multiple conformations in the
structure of FBS_67 RNA. As the KCl concentration was increased in the range 0 – 100
mM, the resonances corresponding to the imino protons involved in G-quadruplex
formation increased in intensity and became somewhat more well-defined while the
resonances corresponding to canonical base pairing remained constant. These results
indicate unambiguously that one or more G-quadruplex structures that are stabilized by
K+ ions are present in FBS_67 RNA.
Circular dichroism (CD) spectroscopy was employed next to gain information
about the G-quadruplex fold of FBS_67 RNA. A positive band whose intensity increased
upon KCl titration at 265 nm and a negative band at 240 nm were observed, signatures of
parallel-type G-quadruplex structures (figure 3.2) (34, 35).
Next, we performed non-denaturing polyacrylamide gel electrophoresis (native
PAGE) in the presence of increasing KCl concentrations and at different FBS_67 RNA
concentrations in order to determine if this sequence formed multiple conformations that
migrated at different rates throughout the gel. Several bands were observed for FBS_67
RNA at all KCl concentrations investigated in the range 0 – 100 mM and at all RNA
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Figure 3.2 Circular dichroism (CD) spectra of FBS_67 RNA upon addition of KCl up to
75 mM. The presence of the positive peak at 265 nm and of the negative peak at 240 nm
indicates the formation of a parallel G-quadruplex in the presence of K+ ions.

concentrations investigated in the range 5 – 20 µM (figure 3.3), confirming that FBS_67
RNA adopts multiple conformations as suggested by the 1D 1H-NMR spectra. The
formation of alternate G-quadruplex structures is not uncommon when working with
isolated RNA sequences, and in an attempt to solve this problem, two shorter fragments,
FBS_Q1 RNA (15 nt, position 1602 – 1616 within the FMR1 gene) and FBS_Q2 RNA
(19 nt, position 1617 – 1635 within the FMR1 gene), whose sequences were predicted to
adopt G- quadruplex structures, were produced by in vitro transcription reactions (table
2.1).
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Figure 3.3 (A) Native polyacrylamide gel electrophoresis (PAGE) of FBS_67 RNA at
different RNA concentrations in a fixed concentration of 50 mM KCl. Several
conformations exist at each concentration of RNA. (B) Native PAGE of FBS_67 RNA at
a fixed concentration of 20 µM in the presence of increasing concentrations of KCl.
Several conformations exist in the gel at all KCl concentrations.

3.2

Characterization of FBS_Q1 RNA and FBS_Q2 RNA
Once again, 1D 1H-NMR was employed to investigate G-quadruplex formation

within each of the two short RNA sequences, FBS_Q1 RNA and FBS_Q2 RNA. As seen
in figure 3.4, even in the absence of KCl, resonances are present in the region 10 – 12
ppm, corresponding to imino protons of guanines involved in G-quartet formation,
indicating the presence of a G-quadruplex structure in FBS_Q1 RNA. Upon the titration
of KCl up to 25 mM, these imino proton resonances become sharper, indicating that the
FBS_Q1 G-quadruplex is stabilized by K+ ions. Since the annealing of this sample
results in even sharper resonances (figure 3.4, top spectrum), all further experiments were
performed with annealed FBS_Q1 RNA samples.

No imino proton resonances

corresponding to Watson-Crick base pairs were present in the region 12 – 15 ppm,
indicating the absence of alternate duplex conformation, which was expected as the
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Figure 3.4 1D 1H-NMR spectra of FBS_Q1 RNA in the presence of increasing KCl
concentrations. The G-quadruplex (10 – 12 ppm) forms in 0 mM KCl, but the imino
proton resonances increase in intensity and sharpness upon the addition of KCl. Amino
proton resonances are also present between 8.6 and 10 ppm, and all resonances become
sharper once the sample is boiled for 5 minutes and annealed.

sequence is made up entirely of guanines and adenines, which are incapable of forming
Watson-Crick base pairs. It is interesting to note the presence of two unusually sharp and
downfield guanine amino resonances at 9.9 ppm and 10.0 ppm. Sharp and downfield
shifted guanine amino proton resonances observed in G-quadruplex forming sequences
containing 5’-GGAGG-3’ stretches have been attributed to the presence of an
A:(G:G:G:G):A hexad in the structure in which two guanines have both of their amino
protons hydrogen bonded, one to a neighboring guanine in the G-quartet and the second
to the N7 of the adenine to form a hexad (figure 3.5) (86-90). A second set of sharp and
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Figure 3.5 An RNA hexad is formed by two adenines that are in the plane with the Gquartet. The formation of a hexad stabilizes the amino protons that are involved in
Hoogsteen base pairing within the G-quartet.

downfield shifted amino protons were observed at 8.60 ppm and 8.80 ppm, and a broader
one at 8.73 ppm. 2D 1H-1H homonuclear Overhauser enhancement NMR spectroscopy
(NOESY) experiments revealed strong NOE cross peaks between the two hydrogen
bonded amino protons in each of the two guanines involved in the formation of the
hexad: for the first guanine (10.0 ppm; 8.8 ppm), (11.5 ppm; 10.0 ppm) and (11.5 ppm;
8.8 ppm) and for the second guanine (9.9 ppm; 8.6 ppm), (11.4 ppm; 9.9 ppm) and (11.4
ppm; 8.6 ppm) (figure 3.6). These results are consistent with the presence of a hexad
structure in which both amino protons of two guanines are involved in hydrogen bonding.
Furthermore, proton-deuterium exchange experiments revealed that the same set of imino
protons (at 11.5 ppm and 11.3 ppm) and amino proton pairs (at 10.0 ppm, 8.8 ppm and
9.9 ppm, 8.6 ppm, respectively) for which strong NOE cross peaks were observed in the
NOESY experiments exchange very slowly (hours or days) as compared to the rest of the
imino protons present in the spectrum (seconds or minutes) (figure 3.7). This exchange
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Figure 3.6 2D 1H-1H-NOESY of FBS_Q1 RNA in the presence of 25 mM KCl. The
dotted lines show the relationship between the NOEs and the 1D 1H-NMR spectrum of
FBS_Q1 RNA.

with the solvent, which requires the base pairs to open transiently, is slowed down
considerably when both amino protons of some of the guanines are involved in hydrogen
bonding, as predicted in the hexad structure (figure 3.5). Taken together the 1D 1H-NMR
spectra, the 2D 1H-1H NOESY spectrum, and the1D deuterium exchange NMR spectra
strongly suggest that the FBS_Q1 RNA sequence adopts a G-quadruplex structure that
contains an A:(G:G:G:G):A hexad.
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Figure 3.7 1D 1H-NMR spectra of FBS_Q1 RNA, which was lyophilized and resuspended in deuterium oxide (D2O).

When FBS_Q2 was analyzed by 1D 1H-NMR spectroscopy, a set of resonances
corresponding to the imino protons of guanines and uracils involved in Watson-Crick
base pairs were observed in the region 12 – 14 ppm at all KCl concentrations
investigated, whereas the characteristic G-quadruplex imino proton resonances centered
around 11 ppm were not observed until 25 mm KCl had been titrated into the sample
(figure 3.8). The G-quadruplex imino proton resonances increased in intensity as more
KCl was titrated up to 60 mM KCl in FBS_Q2 RNA, but this titration did not affect the
intensity of the Watson-Crick base pairs, suggesting that FBS_Q2 RNA adopts alternate
conformations involving Watson-Crick base pairing independent of the G-quadruplex
structure forming upon the addition of KCl.
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Figure 3.8 1D 1H-NMR spectra of FBS_Q2 RNA at varying concentrations of KCl. The
G-quadruplex region of the spectra between 10 and 12 ppm appears and increases upon
increasing concentrations of KCl up to 60 mM. Watson-Crick base pairing can be seen
as imino proton resonances between 12 and 14 ppm that do not change upon KCl
titration.

To investigate if each of the two sequences, FBS_Q1 RNA and FBS_Q2 RNA,
exists in a single conformation at various KCl concentrations, native PAGE was
employed. FBS_Q1 RNA was observed to form a single band on the native PAGE at 25
mM KCl and 50 mM KCl while it was observed to form two distinct conformations at 0
mM KCl as well as at KCl concentrations in the range 75 – 150 mM (figure 3.9 A). At
25 mM KCl, FBS_Q1 RNA was observed to form a single conformation by native PAGE
at various concentrations of RNA in the range 10 – 40 µM (figure 3.9 B). The secondary
band at higher concentrations of KCl seen in figure 3.9 (A) could represent secondary
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Figure 3.9 (A) Native PAGE of FBS_Q1 RNA in the presence of increasing KCl
concentrations. The sequence forms more than one conformation at KCl concentrations
above 50 mM, but it appears to form only one conformation in the presence of 25 mM
KCl and 50 mM KCl. (B) Increasing concentrations of FBS_Q1 RNA forming one
conformation in 25 mM KCl.

structure in which the hexad formed by FBS_Q1 RNA stacks upon another hexad in
order to form a dimer upon increasing KCl concentrations, a phenomenon commonly
observed in hexad forming sequences (86).
Although the 1H-NMR spectroscopy results suggested that the sequence of
FBS_Q2 RNA formed more than one conformation, one of which involved Watson-Crick
base pairing, this RNA migrates as a single band in native PAGE experiments at all KCl
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Figure 3.10 (A) Native PAGE of FBS_Q2 RNA in the presence of increasing KCl
concentrations and (B) increasing concentrations of RNA at a fixed concentration of 25
mM KCl. The sequence forms only one conformation at KCl concentrations in the range
0 mM to 150 mM and RNA concentrations in the range 10 – 40 µM.

concentrations in the range 0 – 150 mM (figure 3.10). Thus, it is possible that the
alternate conformations adopted by FBS_Q2 RNA cannot be distinguished based on their
migration pattern through native PAGE experiments.
To gain information about the G-quadruplex fold of FBS_Q1 RNA and FBS_Q2
RNA, CD spectroscopy was once again utilized (figure 3.11). As expected from the 1HNMR data that showed a G-quadruplex forming in the absence of KCl, FBS_Q1 RNA
has the signature positive band at 265 nm and a negative band at 240 nm of a parallel Gquadruplex structure in the absence of KCl. Even upon the titration of increasing KCl
concentrations, the signature bands of parallel G-quadruplex formation remain constant
(figure 3.11 A).

The 1H-NMR spectra of FBS_Q2 RNA showed the absence of

resonances in the G-quadruplex region in the absence of KCl and the increase in Gquadruplex character upon the titration of KCl into the sequence. Similarly, the CD
spectrum of FBS_Q2 RNA indicates that a parallel G-quadruplex is forming only upon
the titration of KCl up to 25 mM with a positive band at 265 nm and a negative band at
240 nm (figure 3.11 B). In the absence of KCl, the positive band is centered at 270 nm, a
36

Figure 3.11 Circular dichroism (CD) spectra of FBS_Q1 RNA and FBS_Q2 RNA. (A)
FBS_Q1 RNA upon titration of 25 mM KCl shows the positive band at 265 nm and the
negative band at 240 nm, indicating the formation of a parallel G-quadruplex in the
absence and presence of K+ ions. (B) CD spectra of FBS_Q2 RNA upon the titration of
25 mM KCl shows a positive peak at 265 nm and a negative band at 240 nm, indicating
that FBS_Q2 RNA forms a G-quadruplex upon the addition of K+ ions. At 0 mM KCl,
the positive band is observed at 270 nm, a signature of A-form duplex formation.
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signature of A-form duplex formation within RNA (91), consistent with the 1H-NMR
data in figure 3.8.
To determine if the formation of parallel G-quadruplexes within the short
sequences of FBS_Q1 RNA and FBS_Q2 RNA caused them to be targets of FMRP RGG
box binding, native PAGE was once again employed (Figure 3.12). The synthetic FMRP

Figure 3.12 Native PAGE of (A) FBS_Q1 RNA and (B) FBS_Q2 RNA in the presence
of increasing concentrations of RGG box in 25 mM KCl.

RGG box peptide has been shown to have high binding affinity to G-quadruplex forming
RNA sequences (43-45).

The binding between RNA and the FMRP RGG box is
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observed as a disappearance of the free RNA band, as the RGG box peptide is positively
charged, causing the RNA-peptide complex to migrate towards the cathode, and a distinct
band representing the complex will not be observed. When the FMRP RGG box is
titrated into FBS_Q1 RNA up to a 2:1 ratio of peptide:RNA, the free RNA band
disappears, indicating that the RGG box has high binding affinity for FBS_Q1 RNA
(Figure 3.12 A). However, when the RGG box peptide is titrated into FBS_Q2 RNA in
the same ratios, the free RNA band remains at nearly the same intensity, indicating that
the RGG box does not have high binding affinity for FBS_Q2 RNA alone (Figure 3.12
B). This could be explained by the fact that the 1H-NMR spectra of FBS_Q2 RNA
suggested that multiple conformations existed in this sequence, but all possible
conformations migrated at the same rate along the native PAGE.

One of these

conformations may not have high binding affinity for the RGG box peptide, but it is not
possible to distinguish between these conformations in the binding gel.
Although FBS_Q2 RNA did not have high binding affinity for the RGG box
peptide, the G-quadruplex formed by both FBS_Q1 and FBS_Q2 are proposed to exist
simultaneously and adjacent to one another within the FBS sequence of FMR1 mRNA.
The short FBS_Q1 RNA was found to form a G-quadruplex that also contains an
A:(G:G:G:G):A hexad. However, it is not clear if this hexad formation is induced by the
short FBS_Q1 RNA sequence or if it is also present in a longer FBS stretch. To test this,
FBS_Q1 RNA and FBS_Q2 RNA were combined into a 42 nt sequence named FBSsh
RNA, which retained both proposed G-quadruplexes but was shorter than the initial
FBS_67 RNA, making it more likely that this sequence would form a single
conformation (Table 2.1).
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3.3

Characterization of FBSsh RNA
To investigate the formation of a G-quadruplex within the FBSsh RNA sequence,

1D 1H-NMR was once again employed. As seen in figure 3.13, even at 0 mM KCl, a
broad resonance is present in the region centered at 11 ppm, corresponding to imino
protons of guanines involved in G-quartet formation, whereas, upon the addition of KCl
up to 25 mM, more defined resonances develop under this broad envelope, indicating that
the G-quadruplex structures of FBSsh RNA are further stabilized in the presence of K+
ions. Nonetheless, at all KCl concentrations investigated, the G-quadruplex imino proton
resonances remain broad, which could be due to the presence of multiple G-quadruplex
structures in FBSsh RNA sequence. This may be because the imino proton resonances
from each of the proposed G-quadruplexes resonate in the same region of the 1H-NMR
spectrum, and if two exist simultaneously, their resonances will overlap in the region
centered at 11 ppm. Interestingly, no sharp amino proton resonances, signatures of the
A:(G:G:G:G):A hexad, were observed around 10 ppm, indicating that the hexad structure
is not formed in FBSsh RNA, likely being induced in the isolated FBS_Q1 RNA by the
short length of the sequence. Additionally, in contrast with the 1D 1H-NMR spectra of
FBS_Q2 RNA, no resonances appear in the Watson-Crick base pair region of the 1HNMR spectrum of FBSsh RNA, indicating that this sequence does not form any alternate
conformations that do not involve G-quadruplexes. This confirmed that FBS_Q1 and
FBS_Q2 RNA sequences became more stable G-quadruplexes once incorporated into a
longer sequence with each other. Thus, all subsequent characterization experiments were
performed with the 42 nt FBSsh RNA folded in the presence of 25 mM KCl.
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Figure 3.13 1D 1H-NMR spectra of FBSsh RNA at varying concentrations of KCl.
Resonances are present in the G-quadruplex imino proton region between 10 and 12 ppm
even at 0 mM KCl, their intensity increasing with increasing KCl concentrations. The
resonances are broad in nature, indicating that this sequence is dynamic and may contain
two distinct G-quadruplexes, FBS_Q1 RNA and FBS_Q2 RNA.

To confirm that the 42 nt sequence of FBSsh RNA exists in a single conformation
native PAGE was employed once again (figure 3.14). At 0 mM KCl, FBSsh RNA
migrates in the gel as a single band, which changes position with increasing salt
concentrations up to 150 mM KCl (figure 3.14 B), consistent with the 1D 1H-NMR
spectra. Similarly, a single band is present when several concentrations of FBSsh RNA
in the range 5 – 30 µM were run on a native PAGE in a fixed concentration of 25 mM
KCl (figure 3.14 A).
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Figure 3.14 Native PAGE of FBSsh RNA in the presence of (A) varying concentrations
of RNA and (B) varying concentrations of KCl.

Figure 3.15 Circular dichroism (CD) spectra of FBSsh RNA upon addition of 25 mM
KCl. The increasing positive band at 265 nm and the negative band at 240 nm indicates
the formation of (a) parallel G-quadruplex(es) in the presence of K+ ions.
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To gain additional information about the fold of the G-quadruplexes within
FBSsh RNA, we used CD spectroscopy. The CD spectrum of FBSsh RNA, shown in
figure 3.15, shows a negative band at 240 nm and a positive band at 265 nm that increase
in intensity upon the titration of KCl from 0 to 25 mM. This result, which indicates that
one or more parallel G-quadruplex structures are present in FBSsh RNA, is consistent
with the 1H-NMR spectra of FBSsh RNA, which showed an increase in the intensities of
the G-quartet imino proton resonances upon the titration of K+ ions.
Next, we employed thermodynamic methods to determine if FBSsh RNA folds
into an intermolecular or intramolecular G-quadruplex structure. Thus, UV thermal
denaturation was used to determine the melting temperatures of the FBSsh G-quadruplex
structures at various RNA concentrations in the presence of 25 mM KCl. If a species
contains n number of strands, its melting temperature, T m, depends on the total RNA
concentration, cT (92). In the case of intermolecular G-quadruplex formation, the plot of
1/Tm (°C-1) versus ln[RNA] is a straight line fitting equation 3.1, where R is the
Boltzmann constant (1.986 cal K-1 mol-1) and ΔH°vH and ΔS°vH are the two Van’t Hoff
free energy components enthalpy and entropy, respectively.

3.1
However, if a species is intramolecular, the Tm does not depend upon RNA
concentration. For intramolecular species, n = 1 strand, Tm is independent of cT, and the
slope of the straight line resulting from plotting 1/Tm (°C-1) versus ln[RNA] is zero,
simplifying equation 3.1 to equation 3.2.
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3.2
The Tm of each of the transitions in the UV thermal denaturation of FBSsh RNA at each
RNA concentration was calculated by fitting the curves to equation 3.3 and rearranging
the calculated ΔH°vH and ΔS°vH into equation 3.2 to determine Tm.

3.3
In equation 3.3, AU is the calculated absorbance of denatured RNA while AF is the
calculated absorbance of folded RNA. The experiments were recorded at 295 nm, the
wavelength that has been shown to be sensitive to G-quadruplex denaturation (80). The
UV thermal denaturation of FBSsh RNA at 295 nm in the presence of 25 mM KCl
revealed two distinct hypochromic transitions characteristic of the denaturing of a Gquadruplex, the first with a T m ~ 43 °C and the second with a Tm ~ 70 °C (figure 3.17 A).
This result is consistent with the presence of two distinct G-quadruplex structures in
FBSsh RNA, which was expected considering that the sequence of this RNA has the
potential to form two separate G-quadruplexes. Figure 3.16 shows a model of the most
likely conformation of two individual parallel G-quadruplexes proposed to form by
FBSsh RNA as the combination of FBS_Q1 RNA and FBS_Q2 RNA.
Increasing concentrations of FBSsh RNA in the range 3 to 30 µM were thermally
denatured, monitoring the decrease in absorbance at 295 nm. Each of the two transitions
were fitted to equation 3.3 for each experiment at each concentration of RNA (figure 3.17
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Figure 3.16 Model of FBSsh RNA as a combination of two G-quadruplexes formed by
FBS_Q1 RNA and FBS_Q2 RNA.

B and C). The calculated melting points (equation 3.2) of each transition were plotted
against the RNA concentration (figure 3.17 D) to show that each of the two melting
points of FBSsh RNA were independent of the RNA concentration. A plot of the inverse
melting temperature versus lncT (figure 3.17 E) also yields two linear curves with a slope
of 0, indicating that n = 1 for each transition and that FBSsh RNA forms two
intramolecular G-quadruplexes.
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Figure 3.17 A) UV thermal denaturation curve of several concentrations of FBSsh RNA
from 3 to 30 µM in 10 mM cacodylic acid, pH 6.5, containing 25 mM KCl showing two
hypochromic transitions. The G-quadruplex transitions best fit to equation 3.3 for B)
transition 1 and C) transition 2. D) The melting temperatures of both G-quadruplex
structures of FBSsh RNA are independent of the RNA concentration, and E) the plot of
1/Tm vs ln[FBSsh RNA] yield straight lines at each transition with a slope equal to zero.
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The thermodynamic parameters (standard enthalpy, entropy, and free energy),
shown in table 3.1, for the formation of the FBSsh RNA G-quadruplex structures in 25
mM KCl were determined by fitting the G-quadruplex dissociation transitions present in
the UV melting curves to equation 3.3, which assumes a two-state model (figure 3.17 B
and C) (35).

Table 3.1 Thermodynamic Parameters for G-quartet Structure Formation

Based solely on the UV thermal denaturation experiments, it was not possible to
assign the two hypochromic transitions to the FBS_Q1 and FBS_Q2 G-quadruplexes
within FBSsh RNA. To solve this problem, we constructed a fluorescently labeled RNA
that reports only on the melting of the first quadruplex in the sequence, FBS_Q1 RNA,
by replacing the adenine at position 14 of FBSsh RNA with 2-aminopurine (2AP)
(FBSsh_14AP RNA), shown in red in figure 3.16. 2AP is a highly fluorescent analog of
adenine, which is sensitive to changes in its microenvironment (93, 94). Its substitution
has also been shown not to perturb the formation of G-quadruplexes (10, 43). In contrast
to UV thermal denaturation in which the change in absorbance as a function of
temperature has contributions from all bases in the sequence, thermal denaturation using
fluorescence spectroscopy monitors only the changes in the steady-state fluorescence of
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the 2AP reporter. Because the 2AP fluorophore is located within FBS_Q1, the first Gquadruplex of FBSsh RNA, in these experiments, only the melting of this G-quadruplex
will be observed. FBSsh_14AP RNA was melted in the presence of 25 mM KCl (figure
3.18), and at each temperature point the steady-state fluorescence emission at 371 nm
was corrected to account for the known dependence of the free 2AP emission at 371 nm
upon temperature (section 2.11). As expected, a single transition was

Figure 3.18 Fluorescence spectroscopy thermal denaturation of FBSsh_14AP RNA in
the presence of 25 mM KCl. The transition seen here corresponds to transition 2 from
the UV thermal denaturation of unlabeled FBSsh RNA.

observed for FBSsh_14AP, and upon fitting it with equation 3.3, a melting point of 69.4
± 0.3 °C was calculated (equation 3.2). This result is in very good agreement with the T m
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value of 68.8 ± 1.0 °C determined for transition 2 by the UV thermal denaturation
experiments. Thus, we assign transition 2 to the melting of the FBS_Q1 G-quadruplex
and transition 1 to the melting of the FBS_Q2 G-quadruplex within FBSsh RNA. These
results are consistent with our knowledge that the length of the loops connecting the Gquartet planes affects the stability of the G-quadruplex structure, with shorter loops
forming tighter, more thermodynamically stable structures (35).

Since each of the

connecting loops in the FBS_Q1 have a single nucleotide, this structure was expected to
be more thermodynamically stable and thus have a higher melting point than the second
G-quadruplex, FBS_Q2, which has longer connecting loops on two sides of its structure
(figure 3.16).
Next, the number of K+ ions coordinated to each of the G-quadruplexes was
determined by performing UV thermal denaturation at a fixed FBSsh RNA concentration
of 10 µM and variable KCl concentrations in the range 5 – 150 mM. To calculate ΔG° of
each of the two transitions at each KCl concentration, the curves of each of the two
transitions were again fitted to equation 3.3, and ΔG° was calculated using the Gibbs free
energy equation where T was set to 298.15 K.

The resulting ΔG° at each KCl

concentration and was plotted against log[KCl] according to equation 3.4 (figure 3.19 A
and B).

3.4
The number of K+ ions coordinated to each G-quadruplex was calculated from the
negative slope of the plots (figure 3.19 A and B) to be 3 K+ ions for each G-quadruplex in
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Figure 3.19 Plots of ΔG° as a function of the logarithm of K+ ion concentration for (A)
transition 1 and (B) transition 2 of FBSsh RNA. The number, n, of K+ ion equivalents
released upon the unfolding of FBSsh RNA G-quadruplexes was determined from the
slope to be 3 K+ ions for each transition.
FBSsh RNA. One of each of these K+ ions could be assigned to being coordinated
between the two planes formed by each of the G-quadruplexes. The location of the other
two ions may be interpreted in several different ways. Three K+ ions are released upon
the first transition of FBSsh RNA, which may indicate that one of these K+ ions is
serving to stabilize stacking interactions between the two individual G-quadruplexes.
Also, K+ ions may be coordinating above and below the two stacked G-quartet planes,
serving to further stabilize the two G-quadruplexes. The coordination of more than one
K+ ion to an RNA sequence proposed to form a two layer G-quadruplex has been
observed before (43). Furthermore, a recent crystal structure of a G-quadruplex was
elucidated in which the K+ ions were found to coordinate between the planes of the Gquadruplex, and they were also shown to play a role in stabilizing the loops of the G-
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quadruplex (95). Thus, it is possible that the two K+ ions that are not coordinating
between the two planes formed by FBS_Q1 in the second transition are serving to help
stabilize the short loops in the sequence or the longer strand that is no longer forming a
G-quadruplex at the higher temperatures. However, much higher concentrations of RNA
would be needed to perform high resolution structural studies on FBSsh RNA in order to
determine the actual location of the K+ ions coordinated to the two G-quadruplexes
formed by the sequence.
Our direct characterization of the FBSsh RNA sequence to form two distinct
parallel G-quadruplex structures supports the indirect evidence that Moine and colleagues
collected indicating that two G-quadruplexes existed within the FBS region of the FMR1
mRNA (72). The formation of two G-quadruplexes within the FMR1 gene is important
because the binding of FMRP to this region located close to the three acceptor sites in
exon 15 directly affects the splicing of FMRP into its minor splice isoforms, including
FMRP ISO2 and ISO3, which lack the major site of phosphorylation. Considering that
the phosphorylation/dephosphorylation of FMRP is tightly connected with its translation
regulator function and that the minor splice isoforms ISO2 and ISO3 lack this
phosphorylation site, it is essential to investigate the binding affinities of the different
FMRP splice isoforms, ISO1, ISO2, ISO3, and ISOP, to the FBSsh sequence of the
FMR1 gene (Chapter 4) to determine if the production of these isoforms is controlled by
an auto-regulatory loop.
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CHAPTER 4: CHARACTERIZATION OF THE BINDING OF FMRP
ISOFORMS TO FBS RNA

In chapter 3, we demonstrated that FBSsh RNA forms two specific Gquadruplexes in the presence of KCl: FBS_Q1 RNA and FBS_Q2 RNA. Next, we
analyzed the binding to FBSsh RNA of several FMRP isoforms, ISO1, ISO2, and ISO3
and the phosphomimetic ISOP. FMRP ISO1, ISO2, and ISO3 have been chosen because
ISO1 is the longest isoform of FMRP, and ISO2 and ISO3 are alternatively spliced at
exon 15 within close proximity of the RGG box domain (figure 1.1, chapter 1). This
proximity is important as the RGG box peptide binds with high affinity with Gquadruplex forming RNAs, and the truncation close to the domain has been shown to
affect the binding of FMRP to G-quadruplex forming target RNA sequences (10).
Phosphorylation of FMRP occurs at serine 500 of FMRP ISO1, which is also within close
proximity of the RGG box domain, this site being eliminated in FMRP ISO2 and ISO3.
The phosphorylation of FMRP has been shown to be important in mediating its
translation regulator function (47, 96), and the alternate splicing into minor isoforms of
FMRP, ISO2 and ISO3, prevent FMRP from being re-phosphorylated, possibly
remaining in a prolonged “on” state for translation of its mRNA targets.

4.1

Interactions between FBSsh RNA and the FMRP RGG box peptide
It has been shown that the FMRP RGG box peptide binds with high affinity and

specificity to G-quadruplex forming RNA sequences (42-45). Furthermore, it has been
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shown that super-stoichiometric concentrations of RGG box peptide unwind Gquadruplex forming RNA sequences (43, 44).
To demonstrate that the RGG box peptide binds to the G-quadruplex forming
FBSsh RNA, native PAGE was first utilized. 10 µM FBSsh RNA was incubated with
varying concentrations of FMRP RGG box peptide in the range 2.5 – 20 µM at 25°C in
the presence of 25 mM KCl, and 10 mM cacodylic acid, pH 6.5. The samples were run
on a 15% non-denaturing polyacrylamide gel, which contained 25 mM KCl in the gel as
well as in the running buffer for 6 hours at 75 V (figure 4.1). The RGG box peptide is

Figure 4.1 Native PAGE of FBSsh RNA incubated with increasing ratios of the FMRP
RGG box peptide. Because the peptide is highly positively charged, the complex
formation is quantified by the disappearance of the free RNA band. The free RNA band
disappears completely at a 2:1 ratio of RGG box peptide: RNA.

positively charged and thus will not enter the gel as a free peptide. Because of the
positive nature of the RGG box peptide and since FBSsh RNA is only 42 nt, the complex
formed upon the binding of the RGG box to FBSsh RNA has a less negative charge and
will not be visible as a distinct tight band in the gel (figure 4.1). The binding of the
FMRP RGG box to FBSsh RNA is thus quantified as the disappearance of the free RNA
band. As seen in figure 4.1 lanes 2 – 9, the free FBSsh band decreases in intensity upon
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increasing the concentration of the RGG box in the sample, indicating the formation of
the FBSsh-FMRP RGG box complex. A diffused band appears above the free RNA band
in lanes 2 – 9 in the gel, and its intensity becomes higher as the RGG box concentration
increases, indicating the formation of the RNA-RGG box complex, but the broadness of
the band renders its intensity difficult to quantify.
It has been shown previously that excess RGG box peptide unwinds Gquadruplex forming RNA sequences (43, 44). To determine if excess FMRP RGG box
peptide unwinds FBSsh RNA, increasing ratios of FMRP RGG box peptide were titrated
into a fixed concentration of 10 µM FBSsh RNA, and the spectral changes were
monitored through CD spectroscopy. A shown in figure 4.2, no spectral changes

Figure 4.2 Spectral changes in the CD spectrum of FBSsh RNA upon the addition of up
to 8:1 RGG box:RNA ratios.
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occurred when the FMRP RGG box was present in a 1:1 (not shown) or 1:2 ratio to
FBSsh RNA. However in ratios higher than 4:1, the RGG box unwinds the FBSsh Gquadruplex structures. This result is similar to other reports in which the FMRP RGG box
unwinds the G quadruplex structures of its mRNA targets (43, 44). Because two Gquadruplexes form within FBSsh RNA, it is not possible to distinguish between the
unwinding of one quadruplex versus the other by CD spectroscopy. Regardless of this
impediment, the unwinding of FBSsh RNA by the FMRP RGG box may have important
biological implications with regard to the alternative splicing at exon 15 of FMR1 mRNA
in that unwinding of FMR1 mRNA by super-soichiometric amounts of FMRP isoforms
may allow the sequence to be recognized by proteins that may facilitate the alternative
splicing, such as hnRNP (97).

Furthermore, the FMRP RGG box is an unstructured

RNA binding domain, and the FMRP RGG box peptide is unstructured as well, so we did
not expect to see any contribution to the CD spectrum from the peptide alone. If the
peptide became structured upon binding to the G-quadruplexes formed in FBSsh RNA,
we would still not expect for any contributions to interfere with the unwinding
experiment as amino acid secondary structures are typically observed between 140 and
190 nm in the CD spectrum, not within the range of parallel G-quadruplex formation.

4.2

Interactions between FBSsh RNA and different full-length FMRP isoforms
To obtain quantitative information about the interactions between the different

FMRP isoforms ISO1, ISO2, ISO3 and ISOP and FBSsh RNA, we employed
fluorescence spectroscopy. The FBSsh RNA used in the study, named FBSsh_14AP,
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was constructed by replacing the adenine at position 14 located within the G-quadruplex
formed by FBS_Q1 RNA by 2-aminopurine (2AP, figure 3.17). UV thermal denaturation
and CD spectroscopy of FBSsh_14AP were performed, ensuring that the insertion of 2AP does not affect the secondary structure and stability of the labeled RNA. 2-AP is an
analog of adenine that is highly sensitive to changes in its microenvironment, and it can
replace adenine without affecting the structure of DNA and RNA (93, 94).
Recombinant FMRP isoforms ISO1, ISO2, ISO3, and ISOP were expressed in E.
coli cells and purified by nickel affinity column purification as described in chapter 2
(75).

The identities of ISO1, ISO2, and ISO3 were confirmed by peptide mass

fingerprinting (Genomics and Proteomics Core Laboratories, University of Pittsburgh)
(10). The phosphomimetic mutant, ISOP, in which serine 500 was mutated to aspartic

Figure 4.3 Sodium dodecyl sulfate (SDS) PAGE showing the purity of FMRP isoforms
ISO1 (A), ISO2 (B), ISO3 (C), and ISOP (D). In all of the gels, lane 1 represents a
protein ladder, and lanes 2 through 6 and 2 through 7 in (A) and (B) and (C) and(D),
respectively, represent the eluate from the 500 mM imidazole elution step from the
purification step in the protocol in chapter 2 (75).
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acid, was designed by Sara Katrancha, an undergraduate in the Mihailescu laboratory,
and it was expressed and purified using the same protocol for the other three FMRP
isoforms. The purity of each of the FMRP isoforms was verified by SDS PAGE (figure
4.3). As stated earlier, the phosphorylation of FMRP at serine 500, the major site of
phosphorylation, has been shown to be biologically relevant to the translation regulator
function of FMRP, and the mutation of a serine to aspartic acid or glutamic acid mimics
the phosphorylation of proteins in recombinant proteins (79).
The binding of the FMRP isoforms to a fixed concentration of FBSsh_14AP RNA
was measured by monitoring the 2-AP steady-state fluorescence intensity changes upon
the titration of increasing amounts of each isoform, ISO1, ISO2, ISO3, and the
phosphomimetic isoform, ISOP. A decrease in the steady-state fluorescence of the 2-AP
reporter was observed upon the addition of each FMRP isoform. This change was
observed previously in FMRP steady-state fluorescence binding experiments on
S3Fsh_8AP RNA (10, 75), a fragment of the mRNA encoding the Semaphorin 3F
protein, a known target of FMRP. Each individual binding curve was fitted with equation
2.1 (chapter 2), determining the dissociation constant, Kd, of each isoform binding to
FBSsh_14AP RNA (figure 4.4). These experiments were performed in triplicate for each
isoform, and the reported errors represent the standard deviation of the average Kd of
each curve fit of the data to the equation. As seen in table 4.1, the Kd values for FMRP
ISO1 and ISOP are within error of each other, indicating that the binding of FMRP ISO1
to its own mRNA sequence is not affected by the mutation of Ser500 to aspartic acid,
mimicking the posttranslational modification of phosphorylation. The phosphorylation of
Ser500 has been shown to be important in the exertion of the FMRP translation regulator
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function on some of its target mRNAs (47, 96). Although the mutation we have made on
FMRP ISO1 has been shown to mimic phosphorylation in many instances, it would be
interesting to see how in vitro phosphorylation of FMRP ISO1 would affect the binding

Figure 4.4 FMRP isoforms ISO1, ISO2, ISO3, and ISOP were titrated into free
FBSsh_14AP RNA in the presence of 750 nM BSA and 25 mM KCl. (A) FMRP ISO1
and (B) ISOP bind FBSsh_14AP RNA within error of each other, and (C) FMRP ISO2
and (D) ISO3 bind FBSsh_14AP RNA within error of each other and more tightly than
ISO1 and ISOP. Each plot represents one experimental data fit to the equation, and the
reported Kd values represent the average of three Kd values and an error representing the
standard deviation of the three values.
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of the protein to FBSsh RNA. The phosphomimetic protein did not show a distinctly
different binding affinity for FBSsh RNA, but because the steady-state fluorescence
binding assay is highly sensitive, there may be a difference between the mutated protein
and the in vitro phosphorylated protein. Because of the low yield of recombinant FMRP
isoforms, however, in vitro phosphorylation on FMRP ISO1 has proven to be difficult to
perform in our laboratory. Based on our data, the phosphomimetic FMRP ISO1, ISOP,
does not bind differently to FBSsh RNA than the dephosphorylated ISO1. No other
quantitative data is currently available about the binding of FMRP ISOP to other Gquadruplex forming mRNA targets to determine if the phosphomimetic FMRP ISO1
binds differently to other FMRP RNA targets than ISO1 or if the mutation does not affect
the protein like in vitro phosphorylation would in the binding assays. Thus, it remains to
be seen if this trend is valid for mRNAs whose translation is regulated directly by FMRP.

Table 4.1 Results of the fluorescence binding assays of FMRP isoforms 1, 2, and
3 and ISOP to G-quadruplex forming FBSsh_14AP RNA
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The Kd values for FMRP ISO2 and ISO3 binding to FBSsh_14AP RNA were also
within error of each other yet lower than the Kd values of ISO1 and ISOP binding to
FBSsh_14AP RNA (table 4.1), indicating that the truncation of the protein in the
proximity of the RGG box results in tighter binding to FMR1 mRNA. The Kd values
measured for each FMRP isoform binding to FBSsh_14AP RNA were in the nanomolar
range, similar to values determined for their binding to the G-quadruplex forming
S3Fsh_8AP RNA, another FMRP target mRNA (10).
We performed control experiments in which the steady-state fluorescence of a
non-specific RNA, DLS_9AP RNA, was monitored as FMRP isoforms were added to a

Figure 4.5 Steady state fluorescence spectroscopy emission changes at 371 nm of a 2-AP
reporter located in the terminal loop of a 16 nt control hairpin as FMRP ISO1 - ISO3 or
ISOP are titrated into a fixed concentration of the RNA (150 nm). The sequence of
DLS_9AP RNA is 5’- UCA CGG CG2AP GCU GUG A -3’.
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fixed concentration of 150 nM RNA (figure 4.6). The 2-AP is located in the terminal
loop of the 16 nt DLS_9AP RNA. The addition of the FMRP isoforms to the nonspecific RNA did not have an effect on the fluorescence intensity of the reporter up to
triple the concentration, and even then FMRP ISO3 caused the emission of DLS_9AP
RNA to increase slightly (10).
FMRP ISO1 binding to the G-rich region within FMR1 has been shown to
influence the splicing events at exon 15 (72) by increasing the production of the isoforms
ISO2 and ISO3, which lack the major phosphorylation site at position 500, and
decreasing the production of FMRP ISO1. It has been shown previously that FMR1 -/knockout mice, which produce FMR1 mRNA but not any FMRP isoforms, do not
produce FMR1 mRNA that has been alternatively spliced at exon 15 (72). This is
because FMRP is not available to bind to the FBS RNA sequence in order to control the
alternative splicing into minor mRNA and protein isoforms. Our findings that FMRP
ISO2 and ISO3 isoforms bind FBSsh RNA more tightly than FMRP ISO1 suggests that
the existence of a feedback auto-regulatory loop for the production of the FMRP ISO2
and ISO3. When sufficient amounts of FMRP ISO2 and ISO3 are produced by FMRP
ISO1 binding to the FBS RNA sequence, they can compete with FMRP ISO1 to bind to
the same sequence, shutting down their own production.
As discussed earlier, in its phosphorylated state, FMRP has been shown to be
associated with stalled polyribosomes (96), and in the case of the PSD-95 mRNA target
with the RISC complex (47), suggesting that in this state FMRP prevents the translation
of its mRNA targets. The FMRP dephosphorylation in response to synaptic input, has
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been shown to rescue the PSD-95 mRNA translation (47). The FMRP ISO2 and ISO3
isoforms do not have the ability to be regulated by phosphorylation/dephosphorylation
events. Thus, our findings that they have higher affinity for G-quadruplex forming
FMRP targets than FMRP ISO1 (10) suggests a mechanism by which FMRP ISO2 and/or
FMRP ISO3 prolong the “on” state for translation of these mRNA targets by competing
with FMRP ISO1, which can turn “off” translation by becoming re-phosphorylated. The
levels of the different FMRP isoforms have to be tightly regulated in the cell, as the
expression of specific isoforms could control the timing of the translation of different
FMRP mRNA targets. Our results suggesting that the expression of FMRP ISO2 and
ISO3 is controlled by feedback inhibition are significant, contributing to our
understanding of this complex mechanism of regulation.
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CHAPTER 5: LET-7B miRNA INTERACTIONS WITH MAP1B mRNA

MAP1B mRNA has been shown to form a G-quadruplex structure within its 5’UTR and is a known target of FMRP. After sequence analysis of MAP1B mRNA, it was
discovered that MAP1B mRNA also contained a sequence within its 3’-UTR that
potentially had high binding affinity with the miRNA let-7b, one of the first discovered
miRNAs. Since miRNAs are known to regulate the translation of target mRNAs, it was
of great interest to investigate the binding of let-7b with the proposed MAP1B mRNA
sequence as FMRP may exert its translation repression function in conjunction with let7b miRNA.

5.1

Let7b miRNA interactions with MAP1B sequence 1
The first step in the investigation of the translation regulation function of let-7b

on MAP1B mRNA was to determine whether binding was occurring. In the 3’-UTR of
the MAP1B mRNA, a sequence was identified as a potential binding site for let-7b
miRNA which was a promising discovery considering that miRNAs most commonly
exert their translation repression function by binding to sequences within the 3’-UTR
regions of target mRNAs. The location of this binding sequence within a known FMRP
mRNA target is interesting because FMRP has been shown to interact with the miRNA
pathway. To determine if let-7b miRNA has a translation repression function on the
well-known FMRP target MAP1B mRNA, the potential interactions of let-7b miRNA
and MAP1B mRNA have to be analyzed, and this was the goal of this study. Thus, the
interactions between let-7b miRNA and MAP1B sequence 1 (MAP1B seq1) RNA, shown
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in figure 5.1, was characterized by using 1D 1H-NMR spectroscopy, UV thermal
denaturation, and non-denaturing polyacrylamide gel electrophoresis (native PAGE).
The RNA sequences of let-7b miRNA and MAP1B seq1 RNA were both synthesized by
Dharmacon (Thermo Scientific).

Figure 5.1 Proposed binding of let-7b miRNA to MAP1B seq1 RNA, located in the 3’UTR of MAP1B mRNA.

First, the binding between let7b miRNA and MAP1B seq1 RNA was
characterized by using 1D 1H-NMR spectroscopy.

Figure 5.1 shows the proposed

interactions between let7b miRNA and MAP1B seq1 RNA, consisting of Watson-Crick
and guanine-uracil wobble base pairing, and these interactions have distinct signatures in
1D 1H-NMR spectroscopy in the imino proton resonance region between 10 and 15 ppm
(85). If the imino protons of Gs and Us are not engaged in base pairing, their resonances
will not be observed in the region 10 – 15 ppm due to their fast exchange with water
protons. Figure 5.2 shows that let-7b miRNA and MAP1B seq1 RNA do not form
Watson-Crick base-paired homodimers as no resonances are present in the imino proton
region of their 1H-NMR spectra. This finding is consistent with the secondary structure
predictions we obtained by using RNAStructure 4.0 software, which did not find any
regions of self-complementarity in these RNA sequences. In contrast, once let-7b and
MAP1B seq1 were mixed in a 1:1 ratio at 25°C in 10 mM cacodylic acid, pH 6.5, the 1H64

NMR spectrum reveals numerous resonances in the imino proton region, indicating that
let-7b miRNA and MAP1B seq1 RNA bind by Watson-Crick (12 – 15 ppm and G-U
wobble base pairing (10-12 ppm).

Figure 5.2. 1H-NMR spectra of Let-7b miRNA (bottom green) and MAP1B seq1 RNA
(middle red) alone as well as mixed in a 1:1 ratio (top blue).

To confirm that let-7b was able to bind to MAP1B seq1 RNA, we performed
concentration dependent native PAGE (figure 5.3). Lanes 1 and 6 in figure 5.3 contain
free MAP1B seq1 RNA and let-7b miRNA, respectively, used as controls, whereas lanes
2 – 5 contain mixtures of increasing concentrations of let-7b miRNA in a fixed
concentration of MAP1B seq1 RNA in the following ratios: ¼:1 (lane 2), ½:1 (lane 3),
¾:1 (lane 4), and 1:1 (lane 5). MAP1B seq1 RNA migrates as a monomer (lane 1), but it
is interesting to note that let-7b miRNA migrates through the gel as a larger molecular
weight complex (lane 6). The monomeric single-stranded let-7b miRNA, 22 nt, should
appear as a band migrating at the same rate through the gel as free MAP1B seq1 RNA
based on the difference of only one nucleotide in their sequence length. This result
indicates that let-7b miRNA forms some secondary structure that does not involve the
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formation of canonical Watson-Crick base pairs, as such pairing was not observed in the
imino proton region of its 1H-NMR spectrum (figure 5.2, bottom spectrum). As the
concentration of let7b miRNA increased in the let-7b: MAP1B seq1 mixtures, the band

Figure 5.3. 20% native gel mobility assay of let-7b miRNA titrated into MAP1B seq1
RNA to a final ratio of one-to-one.

corresponding to the free MAP1B seq1 RNA decreased in intensity while the band
corresponding to the let7b miRNA-MAP1B seq1 RNA duplex increased in intensity. At
a 1:1 ratio of miRNA:RNA (lane 5), the free MAP1B seq1 RNA band completely
disappeared, indicating that the let7b miRNA bound to MAP1B seq1 RNA in a 1:1 ratio.
To determine the stability of the duplex formed between let-7b miRNA and
MAP1B seq1 RNA characterized by 1H-NMR spectroscopy and native PAGE, UV
thermal denaturation experiments were performed on the two individual sequences as
well as on their complex formed by mixing them in a 1:1 ratio at 25 °C. As expected, the
absorbance observed at 275 nm of MAP1B seq1 RNA did not change as the temperature
increased from 20 ºC to 95 ºC (figure 5.4, purple data points), indicating that this
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sequence exists as a stable monomer, consistent with the results of the 1H-NMR
spectroscopy and native PAGE experiments. In contrast, the absorbance observed at 275
nm of let-7b miRNA increased as the temperature increased from 20ºC to 95ºC, likely the
result of the thermal denaturation of its secondary structure first suggested by the native
PAGE experiment (figure 5.3, lane 6). When let-7b miRNA and MAP1B seq1 mRNA

Figure 5.4. UV thermal denaturation of let-7b miRNA, MAP1B seq1 RNA, and a 1:1
mixture of let-7b miRNA and MAP1B seq1 RNA.

were mixed in a 1:1 ratio, their thermal denaturation profile observed at 275 nm showed a
clear hyperchromic transition at 39 °C, characteristic of the denaturation of the RNA
duplex upon increasing the temperature. This indicated that the duplex formed by let-7b
miRNA and MAP1B seq1 RNA is stable up to physiological temperature, 37 °C.
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Taken together, the results of 1H-NMR spectroscopy, native PAGE and UV
thermal denaturation prove unambiguously that let-7b miRNA interacts by canonical base
pairing with a sequence located in the MAP1B 3’-UTR in vitro, raising the possibility
that these interactions might also be relevant in vivo. It is possible that FMRP, let-7b
miRNA and the miRISC work together to regulate the translation of the protein product
of MAP1B mRNA, as the interaction between FMRP and MAP1B mRNA (43) and the
interaction between FMRP and the miRISC (61, 65) have been shown.
To test the hypothesis that let-7b miRNA interacts with the 3’-UTR of MAP1B
mRNA to repress its translation and that this interaction is affected by FXS, in vivo
experiments were performed by the Feng group at Emory University in Atlanta, GA.
In those studies, the presence of let-7b miRNA and MAP1B mRNA in the murine
neonatal hippocampus cells used in the study were detected, and it was shown that the
levels of let-7 miRNA were dynamic. Given the expectation that let-7b might act in vivo
to suppress the translation of MAP1B mRNA, the levels of the MAP1B protein were
measured and the levels of the MAP1B protein decreased while the let-7b miRNA levels
increased, suggesting that let-7 miRNA may act to repress the translation of MAP1B
mRNA.
Next the effect of the presence of FMRP on the production of let-7b in the murine
neonatal hippocampus was tested by performing experiments on FMR1 knockout (KO)
mice compared to wild-type (wt) mice. Let-7b miRNA production was shown to be
reduced in the FMR1 KO mice compared to the wt mice compared to a control miRNA,
miR-128, which was not proposed or shown to be affected by the presence or absence of
FMRP.
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Finally, the direct or indirect association of FMRP with let-7b miRNA as well as
the translation repression of MAP1B by let-7b was explored. FMRP and let-7b miRNA
were co-immunoprecipitated in wild-type and knock-out cells, and let-7b miRNA was
shown to be pulled down with FMRP, indicating that FMRP and let-7b miRNA associate
with each other, although the association could be indirect, mediated by the known
association between FMRP and the miRNA pathway member, Ago2 (65). The binding
of let-7b miRNA to MAP1B mRNA was shown to repress its translation in cells.
Furthermore, luciferase reporter assays were performed to show that let-7b binding to the
3’-UTR of MAP1B mRNA added to the 3’-UTR of the luciferase gene indeed represses
translation, consistent with the binding data shown in section 5.1. When the MAP1B 3’UTR was absent from the luciferase gene, translation was not repressed as let-7b is not
proposed to bind to or repress the translation of the luciferase gene.
We showed that let-7b miRNA binds to MAP1B seq1 in a 1:1 ratio, and FMRP
has been shown to bind with high affinity to a G-quadruplex formed in the 5’-UTR of
MAP1B mRNA, signifying that FMRP and the miRNA let-7b may work in conjunction
to regulate the translation of MAP1B mRNA, being further supported by the interaction
between FMRP and the Argonaut (Ago) protein, a key component of the miRNA
pathway. Dr. Yue Feng and colleagues showed that FMRP interacts with let-7b miRNA,
but it was not clear whether this interaction was direct or indirect through another
component of the miRNA pathway since FMRP has already been shown to interact with
Ago2 (65).

Let-7b miRNA was expressed in lower quantities in FMRP KO mice,

indicating that the presence of FMRP affects the overall production of this miRNA. The
lower quantities of let-7b miRNA in FMRP KO mice may contribute to overall
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translation misregulation of MAP1B mRNA in combination with the absence of FMRP.
In the future it may be of interest to monitor the translation repression of MAP1B mRNA
in the presence of both FMRP and let-7b compared to the presence of each individually
by creating a luciferase gene containing both the 5’-UTR and 3’-UTR of MAP1B mRNA.
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CHAPTER 6: CONCLUSIONS

6.1

Analysis of the formation of G-quadruplex structures within a G-rich
sequence of the FMR1 mRNA
A G-rich region of FMR1 mRNA that is bound by FMRP has been analyzed by

various biophysical methods, and two distinct G-quadruplex structures were shown to
form within its structure. The initial sequence analyzed, FBS_67 RNA (67 nt), was
shown to have a very dynamic structure, which involved the formation of several
conformations as seen from its 1H-NMR spectra as well as native PAGE experiments.
The presence of imino proton resonances in the region centered around 11 ppm of the 1HNMR spectrum indicated that this sequence formed a G-quadruplex, even in the absence
of KCl. However, imino proton resonances were also present in the region 12 – 15 ppm,
corresponding to guanine and uracil involved in Watson-Crick base pairing, indicating
the formation of an alternate stem-containing structure.
The long, dynamic FBS_67 RNA sequence was split into two short sequences,
FBS_Q1 RNA (15 nt) and FBS_Q2 RNA (19 nt) (table 2.1), each postulated to form a Gquadruplex structure. FBS_Q1 RNA was found to adopt a G-quadruplex structure that
also contained an A:(G:G:G:G):A hexad, a structure that has not been shown to occur
naturally in RNA sequences but been shown to have some biological relevance as a
secondary structure of an RNA aptamer against bovine prion protein (98). However,
once this short FBS_Q1 RNA sequence was incorporated into the longer 42 nt FBSsh
RNA, the hexad formation was lost, indicating that the hexad was an artifact caused by
the short length of the isolated FBS_Q1 RNA sequence. Interestingly, even upon the
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formation of the hexad in FBS_Q1 RNA, the FMRP RGG box peptide maintained high
binding affinity to this RNA sequence. FBS_Q2 RNA was characterized to form a Gquadruplex only upon the addition of KCl, but its 1H-NMR spectrum also contained
imino proton resonances that correspond to guanine and uracil involved in Watson-Crick
base pairing, indicating that this sequence formed more than one conformation in vitro.
Furthermore, this sequence was found to have low binding affinity with the FMRP RGG
box peptide in native PAGE experiments.
Finally, the two short sequences of FBS_Q1 and FBS_Q2 RNA were combined to
form the 42 nt FBSsh RNA, which was successfully shown to form two distinct Gquadruplexes, which correspond to the individual FBS_Q1 RNA and FBS_Q2 RNA
sequences as shown in figure 3.17, each of which released three K+ ions upon thermal
denaturation. This is significant, as although the G-rich sequence within the coding
region of FMR1 mRNA has been postulated to adopt G-quadruplex structures, their
existence was never proved directly prior to these studies. It was important to show that
two G-quadruplexes form in the coding region of exon 15 of the FMR1 gene because it
shows that FMRP controls the splicing of its own mRNA into its minor isoforms in a Gquadruplex-dependent manner as this RNA sequence is located close to the three acceptor
sites in exon 15.

6.2

Analysis of the differences in binding activity of FMRP ISO1, ISO2, ISO3,
and ISOP to the G-quadruplex forming sequences within FMR1 mRNA
We have also obtained quantitative information about the binding of several

FMRP isoforms to FBSsh RNA by fluorescence spectroscopy. The two shorter splice
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isoforms of FMRP, ISO2 and ISO3, have a higher binding affinity for the FBSsh RNA
than the longest isoform, ISO1 and its phosphomimetic mutant, ISOP. These results are
consistent with the findings that a surplus of the major isoform FMRP ISO1 binding to its
own mRNA switches the translation of FMRP from its major splice isoforms into its
minor splice isoforms. This is significant because it indicates that neuronal cells utilize
the negative feedback loop of FMRP binding to its own mRNA to regulate the alternate
splicing into minor isoforms. Furthermore, the phosphomimetic mutant of FMRP, ISOP,
was shown to bind with the same affinity as ISO1 to FBSsh RNA, indicating that the
phosphorylation of serine 500 does not affect the mechanism of FMRP binding to its own
mRNA and acting as an exonic splicing enhancer. The increase in production of minor
isoforms may have implications for the function of phosphorylated versus
dephosphorylated FMRP since ISO2 and ISO3 do not have the site of phosphorylation
and would thus be present in a “prolonged state” of dephosphorylation. Although the
phosphomimetic FMRP ISO1, ISOP, does not bind significantly differently to its own
mRNA than unphosphorylated FMRP ISO1, the phosphorylation of FMRP is important
in other aspects of FMRP translation regulator function, such as its interaction with the
miRNA pathway with regard to PSD95 regulation (47). Phosphorylated FMRP has also
been shown to interact with stalled ribosomes while dephosphorylated FMRP has been
shown to interact with actively translating ribosomes(96). Our results that FMRP ISOP
and ISO1 have similar binding affinity to its own mRNA, FMRP acting as an exonic
splicing enhancer, support a model in which the phosphorylation of FMRP ISO1 is not
important for its role as an exonic splicing enhancer even though it is important in its role
as a translation regulator. However, despite our findings, in vitro phosphorylation of
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FMRP ISO1 and subsequent steady-state fluorescence binding experiments with FBSsh
RNA would be beneficial in comparison to the phosphomimetic FMRP ISOP to make
sure this mutant is a valid model for quantitative binding experiments.

6.3

Analysis of the binding of let-7b miRNA with the 3’-UTR of MAP1B mRNA
We have shown that let-7b miRNA binds in a 1:1 ratio to a sequence in the 3’-

UTR of MAP1B mRNA (MAP1B seq1), a known target of FMRP. FMRP has been
shown to bind with high affinity to a G-quadruplex formed in the 5’-UTR of MAP1B
mRNA. Furthermore, it has been shown that FMRP interacts directly with components
of the miRNA pathway, specifically the Argonaut (Ago) protein, thus linking MAP1B
mRNA to let-7b miRNA as a translational regulator target. It also suggests that let-7b
miRNA is involved in the translation regulator function of FMRP on MAP1B mRNA,
especially since let-7b miRNA appears to be produced in lower quantities in FMRP KO
mice. The work done at Emory University in the laboratory of Dr. Yue Feng showed that
FMRP may interact directly with let-7b miRNA or indirectly as part of the miRISC since
it was shown to associate with the Ago protein.

6.4

Future Work
As mentioned previously, an important experiment to perform will be in vitro

phosphorylation of FMRP ISO1 in order to compare binding affinities of the mutant
FMRP ISOP with the in vitro phosphorylated FMRP ISO1. A potential problem with this
experiment will be the loss of FMRP ISO1 in the process of phosphorylating the protein,
as the protein tends to precipitate out of solution, and the protein is present in very low
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concentrations already. It is possible that an in vitro phosphorylation assay may produce
even lower yields of FMRP ISO1 or that the already low concentration of FMRP ISO1
may prevent the experiment from occurring efficiently in the first place. Furthermore,
there has been some dispute over what kinase phosphorylates FMRP in vivo (13, 99), and
choosing a kinase for in vitro phosphorylation of FMRP ISO1 may prove to be
problematic in this aspect as well.
Another direction to take the future work of this project is the expression of other
isoforms of FMRP since FMRP ISO1 – ISO3 are not the only isoforms expressed in
human cells. The levels of FMR1 mRNA transcripts in adult mouse brains have been
identified, and the transcript levels of splice isoform 7 appear to be the highest, although
the translation of each of these isoforms has not been directly shown (18). It has been
shown that these transcript isoforms interact directly with polyribosomes, suggesting that
they are being actively translated in neuronal cells (18). FMRP ISO7 lacks exon 12 but is
inclusive of the site of phosphorylation. Since this isoform is suggested to be a major
splice isoform of FMRP, the binding of ISO7 to the G-quadruplex forming FBSsh RNA
may have the effect of increasing the minor splice isoforms ISO8 and ISO9 as a result of
increased concentrations of ISO7, and the binding activity of ISO7 to FBSsh RNA should
be investigated. The loss of exon 12 may have a major impact on the binding of FMRP
to its mRNA targets, as the loss of the RNA binding domain KH1 may change the RNA
binding properties of FMRP even if RNA binding is occurring through the RGG box
domain.
Additionally, the gene analysis of the FMR1 gene of a FXS patient who still
produced FMRP revealed a frame shift mutation that essentially changes the RGG box
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domain. I have been working on expressing and purifying this mutated FMRP, named
FMRP G-insertion (FMRP G-ins), and I have worked on the development of the
expression and purification of the protein.

Optimization of the expression and

purification of FMRP G-ins must be accomplished to investigate the effect of the
mutation on FMRP binding with G-quadruplex forming mRNA targets. Binding studies
have been done using the mutated FMRP RGG box peptide, and it is important to
confirm similar results with the full-length FMRP G-ins.
Another interesting aspect of the association of FMRP and its target mRNAs with
the miRNA pathway to investigate would be the association of both FMRP and let-7b
miRNA with MAP1B mRNA. This could be done by creating a luciferase gene that
contains both the 5’-UTR and 3’-UTR of MAP1B, as the 5’-UTR contains the Gquadruplex to which FMRP binds and the 3’-UTR contains the binding site for let-7b,
which has been shown to repress MAP1B translation.
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